Pain Management Market : Global Market Estimation, Dynamics, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Pain Management Market: By  Seviority (Chronic Pain, Acute Pain By Type ( Pain Managements Drug (NSAIDS, Anesthetics, Antidepressants, Opioids, Anesthetics, Antihistamine Agents, Others), Pain Management Devices (Neurostimulation devices, Ablation Devices, Analgesic Infusion Pumps, Others), By Condition ( Cancer Pain, Musculoskeletal Pain, Neuropathic Pain, Migraine & Facial Pain, Others), By Distribution Channel ( Hospitals, Clinics, Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Pain Management Market size was valued at USD 38.8 billion in 2021 and is expected to reach USD 64.9 billion by 2028, at a CAGR of 7.6% during the forecast period 2022-2028. Pain management caused by the intense damage of the tissue or any other illness. Pain may be the result of injury or different diseases such as diabetic neuropathy, arthritis, osteoarthritis, sclerosis, cancer, fibromyalgia or others. The management of the pain based on the severity and type of the pain. Pain can be classified into two types based on intensity, acute and chronic. Acute pain is sudden onset of the pain whre as chronic pain is persistent, usually due to ageing. There were many pain management solutions available in the market in form of drugs, devices and therapies. The global healthcare system has been influenced by the COVID-19 epidemic. The health officials are working to stop the spread of the coronavirus by enforcing lockdown rules, and most elective and non-urgent surgeries have been postponed around the world. As per the research article published in the Indian Journal of Anaesthesia 2020, COVID-19 has a negative impact on pain clinics, including interventional pain management procedures. The Indian Society of Anaesthesiologists also released recommendations on anaesthesia and intensive care techniques.

Pain Management Market

MARKET SUMMARY
-
7.6%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 7.6%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North-America

Pain Management Market

  • The global pain management market report gives comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global pain management market gives historical, current, and future market sizes (US$ Mn) on the basis of severity of pain, type of treatment, condition, end user and region.
Key Players
  • Medtronic Plc
  • DJO Global Inc.
  • GlaxoSmithKline Plc
  • Johnson and Johnson
  • Novartis AG
Pain Management Market

DRIVERS AND RESTRAINTS

Huge number of factors such as advancements in the pain management techniques such as Neurostimulation devices, increase in ageing population, and established reimbursement scenario are projected to boost the market growth over the forecast period. In addition, high rates of trauma conditions, incidence of the chronic diseases such as arthritis, and cancer expected to bolster the market growth over the forecast period. However, low awareness among the patient pool regarding the availability of low invasive pain management techniques and alternative treatment methods are expected to hamper the market growth over the forecast period.


North-America got Significant Share

Pain Management Market

Geographically, global pain management market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America pain management market projected to have the significant growth rate owing to rise in the number of surgeries, increase in the number of patients suffering with pain and favorable reimbursement policies. Europe pain management market is expected to grow at notable rates owing to the presence of key market players, ageing population, and development of new pain management treatment options for different conditions. Asia Pacific pain management market is projected to have lucrative opportunity of growth owing to the factors such as presence of large patient pool and untapped markets in developing and under developing regions. Development of healthcare infrastructure and public spending on health in countries such as India and China expected to show notable growth rate in the region. For instance, in October 2013, DJO Global has announced that it is planning to launch the 10 pain management devices in India in coming years.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Developments

  • In August 2017, Ajanta Pharma has launched eletriptan hydro bromide tablets for treatment of headaches in US market.
Pain Management Market Segmentation


Location

GEOGRAPHY


Report

Company Profile

Competition Assessment:

  • Medtronic Plc (Ireland)
  • DJO Global Inc. (U.S.)
  • GlaxoSmithKline Plc (U.K.)
  • Johnson and Johnson (U.S.)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)

Description

Pain Management Market size was valued at USD 38.8 billion in 2021 and is expected to reach USD 64.9 billion by 2028, at a CAGR of 7.6% during the forecast period 2022-2028. Pain management caused by the intense damage of the tissue or any other illness. Pain may be the result of injury or different diseases such as diabetic neuropathy, arthritis, osteoarthritis, sclerosis, cancer, fibromyalgia or others. The management of the pain based on the severity and type of the pain. Pain can be classified into two types based on intensity, acute and chronic. Acute pain is sudden onset of the pain whre as chronic pain is persistent, usually due to ageing. There were many pain management solutions available in the market in form of drugs, devices and therapies. The global healthcare system has been influenced by the COVID-19 epidemic. The health officials are working to stop the spread of the coronavirus by enforcing lockdown rules, and most elective and non-urgent surgeries have been postponed around the world. As per the research article published in the Indian Journal of Anaesthesia 2020, COVID-19 has a negative impact on pain clinics, including interventional pain management procedures. The Indian Society of Anaesthesiologists also released recommendations on anaesthesia and intensive care techniques.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX